partner treating kids news report

Akili Expands Prescription Digital Therapeutics Portfolio with TALi Partnership

Reading now: 242
www.additudemag.com

August 18, 2021Akili Interactive, the developer behind the first FDA-approved game-based prescription treatment for ADHD, announced this week that it is partnering with TALi Digital, an Australian-based digital health company, to license its attention-improving game software in the U.S.

provided FDA approval.Under the deal, the two companies will work together to execute clinical trials of TALi’s video game-based technology — designed to screen for and improve early childhood attention impairments — in pediatric ADHD and pursue FDA regulatory clearance.

Upon securing FDA approval, Akili will lead the treatment’s U.S. commercialization and roll-out.The agreement complements Akili’s own flagship product, EndeavorRx, a game-based digital.

Read more on additudemag.com
The website mental.guide is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.